ADHD in the News 2026-01-29
Your Wedding Doesn’t Have to Be Long, Loud or Uncomfortable
Weddings can be challenging for those with neurodivergence. As awareness grows, vendors are creating sensory-friendly solutions.
Nature Outlook: ADHD
The quest to understand and treat a pervasive and mystifying mental health condition.
Limited evidence elimination diet resolves ADHD symptoms
Research shows that eating nutritious meals helps the brain function optimally, but numerous social media posts are claiming that avoiding gluten, dairy, corn and soy can eradicate symptoms of attention deficit hyperactivity disorder (ADHD). Experts said these claims are not backed by robust research, cautioning against strict elimination diets for children.
ADHD and methylphenidate tied to higher adult BMI
Seoul National University Hospital researchers have linked childhood attention-deficit/hyperactivity disorder and methylphenidate exposure with higher adult overweight/obesity and slightly shorter adult height at ages 20 to 25 years.
Mapping the ADHD Brain
Nicholas Fogleman combines brain imaging research with hands-on clinical care to better understand and support children and teens with ADHD.
A new spin on ADHD treatment
Researchers are studying how DJing and hip-hop music production could help improve ADHD symptoms in young adults through creative, non-drug therapy.
For Many Kids on ADHD Pills, It’s the Start of a Drug Cascade
Danielle Gansky was diagnosed with attention-deficit/hyperactivity disorder at age 7. Soon, she was prescribed a daily cocktail of powerful psychiatric drugs that she would be on for years. A new Wall Street Journal investigation reveals that children who start on ADHD medication at a young age are more than five times as likely to be prescribed additional psychiatric drugs. WSJ’s Shalini Ramachandran breaks down that investigation. WSJ’s Ryan Knutson hosts.
In my forties I found out I have ADHD—maybe you do too
They say one way to grab someone’s attention is with a startling piece of data, so get this: Four women were having espresso martinis in San Francisco this past fall. Three were diagnosed with ADHD, or attention-deficit/hyperactivity disorder, as adults. The fourth just assumes she has it.
ADHDers in Love
Key points: Neurodivergent adults often experience higher rates of insecure attachment. They may have vulnerabilities to responding to relational red flags. Neuro‑affirming understanding, predictability, and clear communication are essential.
Paris Hilton Details Her ‘Painful’ Experience with RSD, Compares It to ‘Demon in Your Mind’ Talking Negative to You (Exclusive)
Paris Hilton appeared on Dear Media’s The Skinny Confidential Him & Her Show, where she opened up about her experience growing up with ADHD and rejection sensitive dysphoria
A Missed Opportunity in SEL: Centering Students With Disabilities
Explicitly teaching students social-emotional skills, like social awareness and goal-setting, can lead to stronger relationships, academic gains, and a greater sense of well-being, research shows. Experts say that may be especially true for students with disabilities—but they’re not always considered when schools are designing or implementing SEL curricula.
Continued exposure to certain heavy metals linked to ADHD in childhood
Impulsivity, hyperactivity, and difficulty concentrating are some of the symptoms associated with attention deficit hyperactivity disorder. It is estimated that 6% of schoolchildren in Catalonia suffer to a greater or lesser extent from this neurodevelopmental condition. Although genetic factors are the main cause, environmental factors such as exposure to pollutants can increase the risk of developing ADHD or can intensify its symptoms.
Hostility and Conflict Are More Prevalent in Families of Children With ADHD
Key point: Structural, warm, and noncoercive parenting remains the most effective approach for improving outcomes in children with ADHD.
FDA Accepts NDA for Priority Review: Centanafadine for Treatment of ADHD
Key Takeaways: Centanafadine, a first-in-class NDSRI, shows promise for ADHD treatment across varied age groups, with significant symptom improvement in phase 3 trials. The drug demonstrated a favorable safety profile, with common adverse events being decreased appetite, nausea, and headache, and low abuse potential. Recent studies indicate centanafadine's potential in addressing emotional dysregulation and executive function deficits by modulating neurotransmitter levels. The FDA's priority review of centanafadine's NDA marks a significant step towards offering a novel ADHD treatment option, with a decision expected by July 24, 2026.